In India, an extensive training initiative for tens of thousands of doctors aims to enhance HPV vaccination rates to combat cervical cancer, responsible for a significant global burden. Despite HPV vaccines being available since 2008, uptake remains low due to cost and vaccine misinformation. The government is expected to include a domestically manufactured HPV vaccine in its national immunization program soon, marking a significant step toward reducing cervical cancer cases, especially among young girls. Doctors are mobilizing efforts to educate the public and dispel myths surrounding the vaccine.
Tens of thousands of doctors across India have initiated training programs to promote the HPV vaccine, aiming to eliminate cervical cancer, which is prevalent in the country.
India has seen one in five cervical cancer cases globally, primarily caused by human papillomavirus (HPV), underscoring the urgency for increased vaccination awareness and uptake.
Sutapa Biswas highlighted the misconceptions surrounding HPV vaccine trials, stating that the government and medical community are now focusing on using domestically manufactured vaccines to increase accessibility.
With the new domestic HPV vaccine expected to be included in the national vaccination program, India is presented with an unprecedented opportunity to combat cervical cancer effectively.
Collection
[
|
...
]